NOVA Trial Reaches Primary Endpoint
The Phase 3 NOVA trial of niraparib sponsored by Tesaro, Inc. successfully achieved its primary endpoint in June 2016 of progression-free survival (PFS).
Maria Small, MD Elected to NMA OBGYN Section Board
Congratulations to Maria Small, MD who has been elected secretary/treasurer for the National Medical Association OBGYN Section.
Duke OBGYN Resident, Benjamin Harris, MD, MPH Receives NMA Award
Benjamin Harris, MD, MPH second year resident won the first place in NMA OBGYN Section Resident Research Competition, following a presentation of his research to a panel of judges during
Liz Deans, MD Accepted to APGO Surgical Education Scholars Program
Liz Deans, MD has been accepted to the Association of Professors in Gynecology and Obstetrics (APGO) Surgical Education Scholars P